AQR Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.9M | Buy |
4,137,801
+2,925,372
| +241% | +$33.9M | 0.04% | 552 |
|
|
2025
Q1 | $10.6M | Buy |
1,212,429
+695,227
| +134% | +$6.07M | 0.01% | 854 |
|
|
2024
Q4 | $7.43M | Sell |
517,202
-211,830
| -29% | -$3.04M | 0.01% | 944 |
|
|
2024
Q3 | $16.4M | Buy |
729,032
+413,852
| +131% | +$9.3M | 0.02% | 683 |
|
|
2024
Q2 | $6.13M | Buy |
315,180
+219,945
| +231% | +$4.28M | 0.01% | 941 |
|
|
2024
Q1 | $3.57M | Buy |
95,235
+46,710
| +96% | +$1.75M | 0.01% | 1137 |
|
|
2023
Q4 | $2.72M | Buy |
48,525
+37,564
| +343% | +$2.1M | 0.01% | 1207 |
|
|
2023
Q3 | $452K | Sell |
10,961
-2,850
| -21% | -$118K | ﹤0.01% | 1884 |
|
|
2023
Q2 | $771K | Buy |
+13,811
| New | +$771K | ﹤0.01% | 1661 |
|
|
2021
Q2 | – | Sell |
-27,658
| Closed | -$4.91M | – | 2301 |
|
|
2021
Q1 | $4.91M | Sell |
27,658
-27,998
| -50% | -$4.97M | 0.01% | 831 |
|
|
2020
Q4 | $7.88M | Buy |
+55,656
| New | +$7.88M | 0.01% | 670 |
|